PDE5 inhibition eliminates cancer stem cells via induction of PKA signaling

Saskia Klutzny1,2, Anna Anurin1, Barbara Nicke1

  • 1Bayer AG, Drug Discovery, 13353, Berlin, Germany.

Cell Death & Disease
|February 9, 2018
PubMed

Insights

This study identifies phosphodiesterase type 5 (PDE5) inhibition as a novel strategy to eliminate cancer stem cells (CSCs). PDE5 inhibition targets CSCs by modulating cyclic nucleotide signaling pathways, offering a new therapeutic approach for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer stem cells (CSCs) drive metastasis and treatment resistance, impacting therapy efficacy.
  • Understanding CSC maintenance pathways is crucial for developing targeted therapies.
  • Current strategies specifically targeting CSCs are limited.

Purpose of the Study:

  • To identify novel compounds targeting cancer stem cells (CSCs).
  • To establish a robust screening system for CSC identification and characterization.
  • To investigate the therapeutic potential of targeting CSC maintenance and survival pathways.

Main Methods:

  • Developed an aldehyde dehydrogenase (ALDH)-based phenotypic screening system for automated CSC identification.
  • Utilized high-content single-cell analysis to quantify ALDH-high CSC subpopulations.
  • Conducted a small molecule screen to identify compounds affecting CSCs.
  • Investigated the role of Wnt signaling and PDE5 inhibition in CSC maintenance.

Main Results:

  • Validated high ALDH activity as a reliable marker for CSCs in vitro.
  • Confirmed Wnt signaling is essential for CSC maintenance in SUM149 breast cancer cells.
  • Identified phosphodiesterase type 5 (PDE5) inhibition as a strategy to target CSCs across multiple cancer types.
  • Demonstrated that PDE5 inhibition eliminates CSCs via a novel cGMP- and cAMP/PKA-dependent mechanism, independent of PKG signaling.

Conclusions:

  • ALDH-based screening is effective for identifying CSC subpopulations.
  • PDE5 inhibition represents a promising therapeutic strategy for eliminating CSCs.
  • The identified mechanism of PDE5 inhibition offers new insights into CSC targeting for cancer therapy.

Related Concept Videos

Endocrine Signaling01:45

Endocrine Signaling

Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.3K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
4.5K
Intracellular Signaling Cascades01:24

Intracellular Signaling Cascades

Once a ligand binds to a receptor, the signal is transmitted through the membrane and into the cytoplasm. The continuation of a signal in this manner is called signal transduction. Signal transduction only occurs with cell-surface receptors, which cannot interact with most components of the cell, such as DNA. Only internal receptors can interact directly with DNA in the nucleus to initiate protein synthesis. When a ligand binds to its receptor, conformational changes occur that affect the...
53.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
What is Cell Signaling?02:03

What is Cell Signaling?

Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K